Graves' disease and hyperthyroidism trials in Israel

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Beersheba, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan, Rehovot, Tel Aviv, Tzfat

  Age

  18 years to 75 years

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00
• Phase 2Enrolling by invitation
  A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

  Where

  Beersheba, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv

  Age

  18 years and over

  People

  372 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07286006